SI1567135T1 - Praškasta formulacija za inhaliranje, ki vsebujetiotropij - Google Patents

Praškasta formulacija za inhaliranje, ki vsebujetiotropij

Info

Publication number
SI1567135T1
SI1567135T1 SI200331323T SI200331323T SI1567135T1 SI 1567135 T1 SI1567135 T1 SI 1567135T1 SI 200331323 T SI200331323 T SI 200331323T SI 200331323 T SI200331323 T SI 200331323T SI 1567135 T1 SI1567135 T1 SI 1567135T1
Authority
SI
Slovenia
Prior art keywords
powder formulation
containing tiotropium
inhalation containing
inhalation
tiotropium
Prior art date
Application number
SI200331323T
Other languages
English (en)
Inventor
Mareke Hartig
Michael Trunk
Michael Walz
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32308760&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1567135(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of SI1567135T1 publication Critical patent/SI1567135T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/468-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0001Details of inhalators; Constructional features thereof
    • A61M15/0021Mouthpieces therefor
    • A61M15/0025Mouthpieces therefor with caps
    • A61M15/0026Hinged caps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033Details of the piercing or cutting means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/06Solids
    • A61M2202/064Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
SI200331323T 2002-11-28 2003-11-19 Praškasta formulacija za inhaliranje, ki vsebujetiotropij SI1567135T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10255387A DE10255387A1 (de) 2002-11-28 2002-11-28 Neue Tiotropium-haltige Pulverformulierung für die Inhalation
PCT/EP2003/012911 WO2004047796A2 (de) 2002-11-28 2003-11-19 Neue tiotropium-haltige pulverformulierung für die inhalation
EP03785648A EP1567135B1 (de) 2002-11-28 2003-11-19 Tiotropiumhaltige pulverformulierung für die inhalation

Publications (1)

Publication Number Publication Date
SI1567135T1 true SI1567135T1 (sl) 2008-10-31

Family

ID=32308760

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200331323T SI1567135T1 (sl) 2002-11-28 2003-11-19 Praškasta formulacija za inhaliranje, ki vsebujetiotropij

Country Status (34)

Country Link
EP (1) EP1567135B1 (sl)
JP (1) JP4977321B2 (sl)
KR (1) KR101066805B1 (sl)
CN (1) CN100574751C (sl)
AR (1) AR042242A1 (sl)
AT (1) ATE401861T1 (sl)
AU (1) AU2003294714B2 (sl)
BR (1) BR0316343A (sl)
CA (1) CA2507579C (sl)
CO (1) CO5580736A2 (sl)
CY (1) CY1108420T1 (sl)
DE (2) DE10255387A1 (sl)
DK (1) DK1567135T3 (sl)
EA (1) EA011549B1 (sl)
EC (1) ECSP055821A (sl)
ES (1) ES2310681T3 (sl)
HK (1) HK1085918A1 (sl)
HR (1) HRP20050468A2 (sl)
IL (1) IL168810A (sl)
ME (1) MEP51608A (sl)
MX (1) MXPA05005485A (sl)
MY (1) MY140890A (sl)
NO (1) NO20053090L (sl)
PE (1) PE20040848A1 (sl)
PL (1) PL376229A1 (sl)
PT (1) PT1567135E (sl)
RS (1) RS20050400A (sl)
SA (1) SA04240467B1 (sl)
SI (1) SI1567135T1 (sl)
TW (1) TWI332837B (sl)
UA (1) UA81930C2 (sl)
UY (1) UY28096A1 (sl)
WO (1) WO2004047796A2 (sl)
ZA (1) ZA200502859B (sl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006016904A1 (de) 2006-04-11 2007-10-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalator
DE102008014025A1 (de) * 2008-03-13 2009-09-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalator und Sieb für einen Inhalator
TR200909788A2 (tr) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Tiotropyum içeren inhalasyona uygun kuru toz formülasyonu
PE20130601A1 (es) * 2010-08-03 2013-05-30 Chiesi Farma Spa Formulacion de polvo seco que comprende un inhidor de fosfodiesterasa
WO2014074797A1 (en) * 2012-11-09 2014-05-15 Civitas Therapeutics, Inc. Ultra low density pulmonary powders
KR101748796B1 (ko) * 2015-09-30 2017-06-19 한미약품 주식회사 활성성분의 전달량이 향상된 흡입용 캡슐제
KR101728116B1 (ko) * 2015-11-03 2017-04-18 한미약품 주식회사 티오트로피움 또는 이의 약학적으로 허용가능한 염을 함유하는 흡입용 건조분말 조성물
CN111514418B (zh) * 2019-06-12 2022-01-14 中南大学湘雅二医院 一种自吸式经鼻粉末材料给送装置

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
DE4140689B4 (de) * 1991-12-10 2007-11-22 Boehringer Ingelheim Kg Inhalationspulver und Verfahren zu ihrer Herstellung
DE4318455A1 (de) * 1993-06-03 1994-12-08 Boehringer Ingelheim Kg Kapselhalterung
GB9322014D0 (en) * 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
DE4425255A1 (de) * 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
SK284889B6 (sk) * 1998-11-13 2006-02-02 Jago Research Ag Použitie stearátu horečnatého v suchých práškových formuláciách na inhaláciu
GB9902689D0 (en) * 1999-02-08 1999-03-31 Novartis Ag Organic compounds
UA75375C2 (en) * 2000-10-12 2006-04-17 Boehringer Ingelheim Pharma Method for producing powdery preparations for inhaling
DZ3477A1 (sl) * 2000-10-12 2002-04-18
DE10126924A1 (de) * 2001-06-01 2002-12-05 Boehringer Ingelheim Pharma Inhalationskapseln
DE10141377A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Aufstreuverfahren zur Herstellung von Pulverformulierungen
WO2003084509A1 (en) * 2002-04-04 2003-10-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powder formulations suitable for inhalation
UA80123C2 (en) * 2002-04-09 2007-08-27 Boehringer Ingelheim Pharma Inhalation kit comprising inhalable powder of tiotropium

Also Published As

Publication number Publication date
CA2507579C (en) 2011-07-19
JP2006510622A (ja) 2006-03-30
EA011549B1 (ru) 2009-04-28
CA2507579A1 (en) 2004-06-10
TWI332837B (en) 2010-11-11
ES2310681T3 (es) 2009-01-16
PT1567135E (pt) 2008-09-01
TW200500066A (en) 2005-01-01
CN1717225A (zh) 2006-01-04
DK1567135T3 (da) 2008-10-27
PE20040848A1 (es) 2005-01-14
CY1108420T1 (el) 2014-04-09
ECSP055821A (es) 2005-08-11
KR20050086887A (ko) 2005-08-30
WO2004047796A2 (de) 2004-06-10
KR101066805B1 (ko) 2011-09-22
CN100574751C (zh) 2009-12-30
NO20053090D0 (no) 2005-06-23
NO20053090L (no) 2005-06-23
AU2003294714A1 (en) 2004-06-18
HRP20050468A2 (en) 2006-07-31
EP1567135A2 (de) 2005-08-31
MY140890A (en) 2010-01-29
CO5580736A2 (es) 2005-11-30
AR042242A1 (es) 2005-06-15
UY28096A1 (es) 2004-06-30
WO2004047796A3 (de) 2004-09-30
DE50310208D1 (de) 2008-09-04
ZA200502859B (en) 2006-02-22
DE10255387A1 (de) 2004-06-09
JP4977321B2 (ja) 2012-07-18
EA200500864A1 (ru) 2006-02-24
ATE401861T1 (de) 2008-08-15
AU2003294714B2 (en) 2009-10-08
RS20050400A (en) 2007-04-10
PL376229A1 (en) 2005-12-27
BR0316343A (pt) 2005-09-27
UA81930C2 (uk) 2008-02-25
EP1567135B1 (de) 2008-07-23
SA04240467B1 (ar) 2008-10-15
MXPA05005485A (es) 2005-07-25
IL168810A (en) 2015-02-26
MEP51608A (en) 2011-02-10
HK1085918A1 (en) 2006-09-08

Similar Documents

Publication Publication Date Title
EG24139A (en) New inhalable powder containing tiotropium
EG24478A (en) New inhalable powder containing tiotropium
EG24456A (en) Powder inhaler
HK1080401A1 (en) Powder inhalation device
IL174496A0 (en) Aerosol formulation for inhalation, containing an anticholinergic agent
EP1635762A4 (en) LOW DOSE INHALABLE PHARMACEUTICAL POWDERS
ZA200503546B (en) Tiotropium containing HFC solution formulations
HK1068007A1 (zh) 粉末吸入器
HK1078793A1 (en) Aerosol formulation for inhalation comprising a tiotropium salt
EP1504780A4 (en) DEVICE FOR SUPPLYING A POWDERY CHEMICAL MEANS INTO THE NOSE CAVE
HK1085918A1 (en) Pulverulent formulation for inhalation containing tiotropium
GB0328630D0 (en) Metered dose inhalation preparations
AU300689S (en) Powder inhalator
AU2003267809A8 (en) Powder inhaler
AU300690S (en) Powder inhalator
AU300687S (en) Powder inhalator
AU2003294927A1 (en) Powder inhalator
AU300688S (en) Powder inhalator
GB0328629D0 (en) Metered dose inhalation preparations
AU2002303993A1 (en) Stable powder inhalation dosage formulation
HU0300162V0 (en) Inhalation apparatus for (powder agent medication) for dry inhaling